Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 3 de 3
Filtrar
Mais filtros










Base de dados
Intervalo de ano de publicação
1.
J Appl Microbiol ; 131(2): 973-987, 2021 Aug.
Artigo em Inglês | MEDLINE | ID: mdl-33354899

RESUMO

AIM: To evaluate the antimicrobial efficacy and wound healing effect of atmospheric pressure cold plasma (APCP) on an infected pressure ulcer (IPUs) model that was created on rats. METHODS: A total of 18 rats was divided into APCP, silver sulfadiazine (AgS) and control groups to have six rats in each group. A third-grade pressure ulcer model was developed on the back of each of the rats, and pressure ulcers were infected by inoculation of multidrug resistance (MDR) Pseudomonas aeruginosa. A portable dielectric barrier discharge device was used to generate cold air plasma. APCP, AgS and saline treatments were carried out once a day for 14 days. The effectiveness of the treatment was evaluated on days 5, 10 and 15. Surface area, depth, pressure ulcer healing scale (PUSH) and microbiological examination were used for evaluation. RESULTS: The results of this study showed that APCP was superior over AgS application and irrigation with saline by means of the reduction in surface area and depth of ulcers. Furthermore, PUSH score in plasma group was lower than other groups and histopathological examination showed a higher epithelization in APCP group. The average reductions of MDR P. aeruginosa for APCP, AgS and control groups were determined as 5·64 ± 1·87, 1·91 ± 0·90 and 1·22 ± 0·88 log10 CFU per gram tissue, respectively. CONCLUSION: Atmospheric pressure cold plasma healed IPUs better than AgS. SIGNIFICANCE AND IMPACT OF THE STUDY: Portable cold plasma devices could be a potential novel treatment modality for the patients who have IPUs.


Assuntos
Gases em Plasma , Úlcera por Pressão , Animais , Antibacterianos , Pressão Atmosférica , Humanos , Gases em Plasma/farmacologia , Úlcera por Pressão/terapia , Distribuição Aleatória , Ratos , Cicatrização
2.
Niger J Clin Pract ; 21(6): 758-765, 2018 Jun.
Artigo em Inglês | MEDLINE | ID: mdl-29888724

RESUMO

OBJECTIVES: The aim of the present study was to compare antibiofilm efficacies of the laser in contact and noncontact application modes and cold atmospheric plasma (CAP) on Staphylococcus aureus biofilm grown on sandblasted, large grit, acid-etched (SLA) titanium discs as an in vitro model of biofilm eradication on dental implant materials. METHODS: S. aureus biofilm was matured on titanium discs for 7 days then, treated with contact and noncontact Er:YAG laser and CAP. Antibiofilm efficacy of laser and plasma treatments were evaluated with colony counting and safranin assays. Surface characteristics of titanium disc were analyzed with scanning electron microscopy and surface roughness measurements. Temperature distribution over titanium discs were presented for the thermal safety assessment of laser and plasma treatments. RESULTS: : CAP resulted in 6-log inactivation of S. aureus biofilm, whereas biofilm inactivation was determined as 1 and 2.7-log for noncontact and contact laser treatments, respectively. Laser and plasma treatments did not cause any alterations on the roughness of titanium discs. Contact laser treatment caused a focal temperature increase up to 58°C, whereas plasma treatment led a uniform temperature distribution on the disc within safe limits. CONCLUSION: CAP showed superior antibiofilm activity on 7-day-old S. aureus biofilm grown over SLA titanium discs, compared to contact and noncontact laser treatment without temperature increase and any damage to the surface of titanium discs.


Assuntos
Biofilmes/efeitos dos fármacos , Implantes Dentários/microbiologia , Lasers de Estado Sólido/uso terapêutico , Peri-Implantite/prevenção & controle , Gases em Plasma/farmacologia , Titânio/química , Biofilmes/crescimento & desenvolvimento , Temperatura Baixa , Contagem de Colônia Microbiana , Implantes Dentários/efeitos adversos , Humanos , Lasers , Microscopia Eletrônica de Varredura , Peri-Implantite/microbiologia , Gases em Plasma/química , Staphylococcus aureus/efeitos dos fármacos , Staphylococcus aureus/crescimento & desenvolvimento , Staphylococcus aureus/fisiologia , Propriedades de Superfície
3.
J Appl Microbiol ; 125(2): 383-397, 2018 Aug.
Artigo em Inglês | MEDLINE | ID: mdl-29624820

RESUMO

AIM: To understand the underlying cellular mechanisms during inactivation of Escherichia coli in response to antimicrobial solution of nonthermal plasma-activated N-acetylcysteine (NAC). METHODS AND RESULTS: The recommended techniques were used to demonstrate E. coli cellular and transcriptomic changes caused associated with peroxynitrite and compared with plasma-treated NAC solution. The findings demonstrate that E. coli cells respond to plasma-treated NAC and undergo severe oxidative and nitrosative stress, and leading to stress-induced damages to different components of bacterial cells, which includes loss of membrane potential, formation of oxidized glutathione (GSSG), formation of nitrotyrosine (a known marker of nitrosative stress), DNA damage, and generated a prominent pool of peroxynitrite. Reverse-transcriptase (RT)-polymerase chain reaction analysis of reactive nitrogen species (RNS) responsive genes indicated their differential expressions. CONCLUSION: For the first time, we report that the plasma-treated NAC solution activates predominantly nitrosative stress-responsive genes in E. coli and is responsible for cell death. SIGNIFICANCE AND IMPACT OF THE STUDY: The reactive species generated in solutions by nonthermal plasma treatment depends on the type of solution or solvent used. The plasma-treated NAC solution rapidly inactivates E. coli, mostly involving highly RNS generated in NAC solution, and has high potential as disinfectant.


Assuntos
Acetilcisteína/farmacologia , Escherichia coli/efeitos dos fármacos , Estresse Nitrosativo/efeitos dos fármacos , Estresse Oxidativo/efeitos dos fármacos , Plasma , Dano ao DNA/efeitos dos fármacos , Escherichia coli/genética , Expressão Gênica/efeitos dos fármacos , Humanos , Ácido Peroxinitroso/metabolismo
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA
...